李俊

2000年至2003年任教務處處長兼藥學專業負責人；

2002年任校長助理兼藥學系主任；

2003年至2008年任安徽醫科大學副校長兼藥學院院長；

2008年3月至2008年10月任安徽醫科大學黨委副書記、副校長；

2008年10月至今2019年8月任安徽醫科大學黨委書記；

2019年8月任安徽醫科大學督導員 ^[1]  。

2018年3月—2020年1月，任安徽省政協港澳台僑和外事委員會副主任。 ^[2-3] 

2018年3月23日，安徽省政協十二屆一次常委會議通過，李俊任安徽省政協港澳台僑和外事委員會副主任。 ^[2] 

2019年8月22日，省委決定：顧家山同志任安徽醫科大學黨委委員、常委、書記。李俊同志不再擔任安徽醫科大學黨委書記、常委、委員職務，任安徽醫科大學督導員。 ^[4] 

2020年1月9日，省政協十二屆常委會第十一次會議通過，免去李俊同志的省政協港澳台僑和外事委員會副主任職務。 ^[3] 

1996年安徽醫科大學博士畢業。現任安徽醫科大學校黨委書記。

先後被評為安徽省首批跨世紀學科帶頭人後備人選及安徽省學術和技術帶頭人、國家教育部首批骨幹教師、安徽省教育系統勞動模範，並被授予模範教師稱號，1999年被授予全國“五一”勞動獎章，2000年獲國務院政府津貼，2006年獲安徽省高等學校省級教學名師獎。

長期從事抗炎免疫藥理學、臨牀藥理學和天然藥物活性研究，目前承擔國家自然科學基金資助項目、國家重大基礎研究前期（973前期）研究、國家科技部863資助項目、高等學校博士學科點專項科研基金等40多項課題研究。

獲安徽省自然科學一、二等獎各1項，三等獎2項；安徽省省級教學成果獎一等獎2項、二等獎和三等獎各1項，安徽省青年科技獎1項。近3年發表學術論文100餘篇，其中SCI源期刊收錄30餘篇，主編和參編教材、著作30餘部。

作為課程負責人的《臨牀藥理學》2008年被評為國家精品課程。以第一完成人提出的2項專利申請獲發明專利證書；另有7項專利經國家知識產權局已進入實質審查程序。

培養畢業藥學博士後1人，藥理學博士生14人，藥理學碩士生32人，目前在讀藥學博士後1人，藥理學博士生15人，藥理學碩士生37人，藥劑學碩士生7人，中藥學碩士生8人。

(1) Bian, E.B., C. Huang, H. Wang, B.M. Wu, L. Zhang, X.W. Lv, J. Li*, DNA methylation: New therapeutic implications for hepatic fibrosis, Cell Signal, 25(1): 355-358, 2013.

(2) Yang, Y., Y. Huang, C. Huang, X. Lv, L. Liu, Y. Wang, J. Li*, Antifibrosis effects of triterpene acids of Eriobotrya japonica (Thunb.) Lindl. 1eaf in a rat model of bleomycin-induced pulmonary fibrosis, J Pharm Pharmacol, 64(12): 1751-1760, 2012.

(3) Xie, Q.g., S.-C. Wang, J. Li*, IL-17: a potential therapeutic target for rheuma toid arthriti s? Clin Rheumatol 2012.

(4) Xie, Q., S.C. Wang, J. Zhong, J. Li*, MicroRNA-146a, a Good Biomarker and Potential Therapeutic Target for Rheumatoid Arthritis. Genet Test Mol Biomarkers 2012.

(5) Xie, Q., S.C. Wang, J. Zhong, J. Li*, Therapeutic potential of IL-33 in rheumatoid arthritis: A comment about the article by Talabot-Ayer D, et al., "Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis", Joint Bone Spine, 79:32-37, 2012.

(6) Xie, Q., S.C. Wang, J. Li*,Interleukin 22, a potential therapeutic target for rheumatoid arthritis, J Rheumatol, 39(11): 2220-2221, 2012.

(7) Xie, Q., S.C. Wang, J. Li*, RAK1, a potential therapeutic target for rheumatoid arthritis? Rheumatol Int ,2012.

(8) Xie, Q., S.C. Wang, G. Bian, F.L. Zhan, J.K. Xie, J. Li*,Association of MIF-173G/C and MBL2 codon 54 gene polymorphisms with rheumatoid arthritis: a meta-analysis, Hum Immunol, 73(9): 966-971, 2012.

(9) Wu, W., J. Li*, Y. Liu, C. Zhang, X. Meng,Z. Zhou Comparative proteomic studies of serum from patients with hepatocellular carcinoma, J Invest Surg, 25(1): 37-42, 2012.

(10) Wang, J.Q., Y.H. Zou, C. Huang, C. Lu, L. Zhang, Y. Jin, X.W. Lu, L.P. Liu, J. Li*, Protective effects of tiopronin against high fat diet-induced non-alcoholic steatohepatitis in rats, Acta Pharmacol Sin, 33(6): 791-797, 2012.

(11) Miao, C.G., C. Huang, Y. Huang, Y.Y. Yang, X. He, L. Zhang, X.W. Lv, Y. J. Li*, Li MeCP2 modulates the canonical Wnt pathway activation by targeting SFRP4 in rheumatoid arthritis fibroblast-like synoviocytes in rats, Cell Signal, 25(3): 598-608, 2012.

(12) Liu, H., J. Li*, Y. Huang,C. Huang Inhibition of transient receptor potential melastain 7 channel increases HSCs apoptosis induced by TRAIL, Life Sci, 90(15-16): 612-618, 2012.

(13) Hu, C.M., Q. Cao, X.W. Lv, W.M. Cheng, R. Li, J. Li*, Protective effects of total flavonoids from Litsea coreana on alcoholic fatty liver in rats associated with down-regulation adipose differentiation-related protein expression, Am J Chin Med , 40(3): 599-610, 2012.

(14) He, Y., C. Huang, S.P. Zhang, X. Sun, X.R. Long, J. Li*, The potential of microRNAs in liver fibrosis, Cell Signal, 24(12): 2268-2272, 2012.

(15) He, Y., C. Huang, X. Sun, X.R. Long, X.W. Lv, J. Li*, MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4, Cell Signal , 24(10): 1923-1930, 2012.

(16) Bian, E.B., C. Huang, T.T. Ma, H. Tao, H. Zhang, C. Cheng, X.W. Lv, J. Li*, DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats, Toxicol Appl Pharmacol, 264(1): 13-22, 2012.

(17) Zhang, Q., N. Zhang, H.L. Hu, Y. He, M.W. Chen, X.Y. Wang, M.G. Yang, J. Li*, Effect of intensive blood glucose control on quality of life in elderly patients with type 2 diabetes in Anhui Province, Chin Med J (Engl), 124(11): 1616-1622, 2011.

(18) Tao H , Huang C , Yang JJ , Ma TT , Bian EB , Zhang L , Lv XW , Jin Y , J. Li*, MeCP2 controls the expression of RASAL1 in the hepatic fibrosis in rats, Toxicology, 290(2-3):327-333, 2011.

(19) Wu, W.Y., J. Li*, Z.S. Wu, C.L. Zhang, and X.L. Meng, STAT3 activation in monocytes accelerates liver cancer progression. BMC Cancer, 2011. 11:506.

(20) Ma T , Huang C , Meng X , Zhang Q , Zhang L , Lv X , Jin Y , Xie J , J. Li*, Fingerprint analysis of Hawk-tea by high-performance liquid chromatography, Food Chemistry, 129(2):551-556, 2011.

(21) Huang Y , Gao J , Meng XM , Jiang GL , Yang YR , Li H , Liu J , J. Li*, Involvement of mitogen-activated protein kinase activation in cyclooxygenase-2 and transforming growth factor-beta production in alveolar macrophage from chronic bronchitis rats, Immunopharmacol Immunotoxicol, 33(4):645-651, 2011.

(22) Gao, J., Y. Huang, P. Li, D. Xu, J. Li*, Y. Liu, Z. Huang, Q. Wu,X. Shao Antifibrosis effects of total glucosides of Danggui-Buxue-Tang in a rat model of bleomycin-induced pulmonary fibrosis, J Ethnopharmacol, 136(1): 21-26, 2011.

(23) Zhou, X.D., Y. Gao, Z. Guan, Z.D. Li, J. Li*, Population pharmacokinetic model of digoxin in older Chinese patients and its application in clinical practice, Acta Pharmacol Sin, 31(6): 753-758, 2010.

(24) Xiong, Z., J. Li*, T. Li, J. Shen, F. Hu, and M. Wang, Prevalence of plasmid-mediated quinolone-resistance determinants in Shigella flexneri isolates from Anhui Province, China. J Antibiot (Tokyo), 63(4):187-189, 2010.

(25) Wei, Z., X. Cheng, H. Li, Y. Cao, L. Cong, P. Zhou, J. Li*, Effects of prolonging administration gonadotropin on unexpectedly poor ovarian responders undergoing in vitro fertilization, Reprod Biol Endocrinol, 8(26), 2010;

(26) Wang, T.Y., J. Li*, C.Y. Li, Y. Jin, X.W. Lu, X.H. Wang,Q. Zhou Leflunomide induces immunosuppression in collagen-induced arthritis rats by upregulating CD4+CD25+ regulatory T cells, Can J Physiol Pharmacol, 88(1): 45-53, 2010.

(27) Wang, J.J., J. Li*, L. Shi, X.W. Lv, W.M. Cheng, and Y.Y. Chen, Preventive effects of a fractioned polysaccharide from a traditional Chinese herbal medical formula (Yu Ping Feng San) on carbon tetrachloride-induced hepatic fibrosis, J Pharm Pharmacol, 62(7):935-942, 2010.

(28) Tang, W.J., Z.C. Lin, M.F. Tang, J. Li*, 1,2,3-Tri-O-acetyl-5-de-oxy-d- ribofuran-ose, Acta Crystallogr Sect E Struct Rep Online, 66(Pt 12): o3107, 2010.

(29) Lu, Y.X., Q. Zhang, J. Li*, Y.X. Sun, L.Y. Wang, W.M. Cheng,X.Y. Hu, Antidiabetic effects of total flavonoids from Litsea Coreana leve on fat-fed, streptozotocin-induced type 2 diabetic rats, Am J Chin Med, 38(4): 713-725. 2010.

(30) Li R , Cai L , Xie XF , Yang F , J. Li*, Hesperidin suppresses adjuvant arthritis in rats by inhibiting synoviocyte activity, Phytother Res, 24 Suppl 1:S71-76, 2010.

(31) Li, R., L. Cai, X.F. Xie, L. Peng,J. Li*, 7,3'-dimethoxy hesperetin induces apoptosis of fibroblast-like synoviocytes in rats with adjuvant arthritis through caspase 3 activation, Phytother Res, 24(12): 1850-1856, 2010.

(32) Huang, C., T. Ma, X. Meng, X. Lv, L. Zhang, J. Wang, J. Li*, Potential protective effects of a traditional Chinese herb, Litsea coreana Levl., on liver fibrosis in rats, J Pharm Pharmacol, 62(2): 223-230, 2010. ^[5]